1. Home
  2. RNXT vs AKTX Comparison

RNXT vs AKTX Comparison

Compare RNXT & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • AKTX
  • Stock Information
  • Founded
  • RNXT 2012
  • AKTX N/A
  • Country
  • RNXT United States
  • AKTX United States
  • Employees
  • RNXT N/A
  • AKTX N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNXT Health Care
  • AKTX Health Care
  • Exchange
  • RNXT Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • RNXT 31.6M
  • AKTX 32.8M
  • IPO Year
  • RNXT 2021
  • AKTX N/A
  • Fundamental
  • Price
  • RNXT $1.14
  • AKTX $1.12
  • Analyst Decision
  • RNXT Strong Buy
  • AKTX
  • Analyst Count
  • RNXT 1
  • AKTX 0
  • Target Price
  • RNXT $9.00
  • AKTX N/A
  • AVG Volume (30 Days)
  • RNXT 195.7K
  • AKTX 25.4K
  • Earning Date
  • RNXT 03-31-2025
  • AKTX 02-15-2025
  • Dividend Yield
  • RNXT N/A
  • AKTX N/A
  • EPS Growth
  • RNXT N/A
  • AKTX N/A
  • EPS
  • RNXT N/A
  • AKTX N/A
  • Revenue
  • RNXT N/A
  • AKTX N/A
  • Revenue This Year
  • RNXT N/A
  • AKTX N/A
  • Revenue Next Year
  • RNXT N/A
  • AKTX N/A
  • P/E Ratio
  • RNXT N/A
  • AKTX N/A
  • Revenue Growth
  • RNXT N/A
  • AKTX N/A
  • 52 Week Low
  • RNXT $0.77
  • AKTX $0.90
  • 52 Week High
  • RNXT $1.86
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 36.31
  • AKTX 46.66
  • Support Level
  • RNXT $1.09
  • AKTX $1.10
  • Resistance Level
  • RNXT $1.40
  • AKTX $1.35
  • Average True Range (ATR)
  • RNXT 0.10
  • AKTX 0.13
  • MACD
  • RNXT -0.03
  • AKTX -0.00
  • Stochastic Oscillator
  • RNXT 8.51
  • AKTX 30.77

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: